Stacy Cline Amin and Nate Mendell spoke to Law360 about some of the hottest topics that False Claim Acts practitioners will be tracking in 2023.
“[The U.S. Department of Justice’s ability to end fraud suits] is a powerful tool to defend agency policies and programs, such [as] FDA’s [U.S. Food & Drug Administration] authority to determine when a violation of the Federal Food, Drug, and Cosmetic Act has occurred and the appropriate remedy,” Stacy said.
Looking ahead, Nate predicted that “2023 may be the year we see enforcers use the False Claims Act to punish inadequate cybersecurity protections that leave confidential patient information vulnerable to hacking.”
“Prosecutors will be increasingly drawn to this area,” Nate said, because of “the importance of patient privacy and the increasing threat of sophisticated ransomware and cyberattacks on the health care industry.”
Read the full article.